Cardiovascular Diseases Clinical Trial
To determine the effects of behavioral stress and reproductive hormones on coronary heart disease (CHD) risk.
DESIGN NARRATIVE:
The behavioral study determines whether sex differences in stress responses may assist in
explaining sex differences in CHD. The ongoing research program has documented differences
in psychological responses to acute stress between men and women and among women who vary in
reproductive hormone status. Building on these findings, but also departing from previous
efforts in strategy and design, five studies are conducted. Study 1 measures hemodynamic
measures that underlie sex differences in cardiovascular responses to behavioral challenge.
Using longitudinal designs, Study 2 compares women's stress responses prior to and three
months after surgical menopause, whereas Study 3 compares healthy women's stress responses
prior to and three months after a "temporary menopause" due to the administration of a GnRH
agonist. In both studies, some women after the second testing are administered estrogen
replacement therapy and stress responses are again measured. Thus, Studies 2 and 3 also
address the effects of estrogen replacement therapy on stress responses. These studies gain
significance from the fact that surgical menopause is associated with heightened risk for
CHD, whereas estrogen replacement therapy is associated with protection from CHD. Study 4
describes the extent of sex differences in exposure to psychological stressors among men and
women from two levels of social class. Social class is included in the design because it is
a risk factor for psychological stress and for CHD. The final study tests the hypothesis
that sex differences in stress responses are attenuated during a task within a feminine area
of competency and accentuated during a task within a masculine area of competency.
The study completion date listed in this record was obtained from the "End Date" entered in
the Protocol Registration and Results System (PRS) record.
;
N/A
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|